HIF1A and thyroid gland carcinoma: Interestingly, the modulation of Hif-1α expression can affect the sensitivity to radiotherapy in thyroid neoplasia and to chemotherapy in multiple tumours [77], making it a promising therapeutic target for many cancer types, including thyroid carcinomas [78].